KL
Therapeutic Areas
Uvax Bio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| HIV-1 Vaccine | HIV-1 prevention | Pre-clinical |
| Undisclosed Asset 1 | Infectious Disease | Research |
| Undisclosed Asset 2 | Infectious Disease | Research |
| Undisclosed Asset 3 | Infectious Disease | Research |
| Drug | Indication | Phase |
|---|---|---|
| HIV-1 Vaccine | HIV-1 prevention | Pre-clinical |
| Undisclosed Asset 1 | Infectious Disease | Research |
| Undisclosed Asset 2 | Infectious Disease | Research |
| Undisclosed Asset 3 | Infectious Disease | Research |